Cardiology
|
February 25, 2025

Takayasu's Arteritis: Causes, Symptoms and Treatment

Written By
Dr. Ayesha Bryant MSPH, MD
Medically Reviewed by
Updated On
March 3, 2025

Takayasu's arteritis, also known as the “pulseless disease,” is a rare but serious condition that affects the body's largest arteries. It often leads to reduced blood flow to vital organs. It primarily affects young women, particularly those of Asian, Middle Eastern, or Latin American descent. 

Early diagnosis and treatment may help slow disease progression and manage symptoms, but ongoing medical care is essential. This article explores the causes, symptoms, diagnosis, and treatment options for Takayasu's arteritis.

[signup]

What is Takayasu's Arteritis?

Takayasu's arteritis is a chronic inflammatory condition that affects medium and large arteries, leading to narrowed or blocked blood vessels. The exact cause remains unknown, but it is believed to be an autoimmune disorder.

Historical Background

Takayasu's arteritis was first described in 1908 by Dr. Mikito Takayasu, a Japanese ophthalmologist who noticed unusual blood vessel patterns in his patients' eyes. Since then, research has expanded our understanding of the disease, but its exact triggers remain unclear.

Epidemiology  

Takayasu's arteritis has an estimated worldwide prevalence of 1-2 cases per million people annually. It primarily affects women of Asian, African, and Latin American descent, typically between ages 15 and 40. However, the disease can occur in people of all ages and backgrounds.

Pathophysiology

Takayasu's arteritis primarily affects the aorta and its major branches. It leads to progressive thickening, narrowing, and, in some cases, complete blockage of blood vessels, significantly impacting circulation.  

Inflammatory Processes

In Takayasu’s arteritis, the immune system mistakenly attacks the walls of large arteries, leading to chronic inflammation. This inflammatory process involves immune cells such as macrophages and T-cells, which release cytokines contributing to arterial damage. 

Over time, this can result in thickening, scarring, and narrowing of blood vessels, restricting blood flow to organs. In some cases, this may increase the risk of complications such as high blood pressure, aneurysms, or strokes. The severity of vascular damage varies between individuals, emphasizing the importance of early intervention.

Vascular Impact

As inflammation progresses, the arterial walls undergo structural damage, leading to various complications:

  • Stiffening and narrowing of arteries: Thickened arterial walls lose elasticity, restricting blood flow and increasing blood pressure.
  • Aneurysm formation: Weakened arterial walls may bulge outward, increasing the risk of rupture.
  • Ischemic damage to organs: Reduced blood flow to organs like the heart, brain, kidneys, and limbs can lead to serious conditions, including strokes, heart attacks, or kidney failure.
  • Collateral vessel formation: In response to chronic blockage, the body may form alternative blood vessels (collateral circulation) to bypass affected arteries. However, these vessels are often insufficient to meet the body's needs.

Causes and Risk Factors

The exact cause of Takayasu’s arteritis is unknown, but research suggests a combination of genetic and environmental factors.

Genetic Predispositions

Genetic factors appear to play a role in Takayasu’s arteritis:

  • HLA-B52: Individuals with the HLA-B52 gene have been found to have a higher risk of developing Takayasu’s arteritis. However, not everyone with this genetic marker will develop the condition, suggesting additional factors are involved.
  • Familial clustering: While Takayasu’s arteritis is not directly inherited, cases of the disease occurring in multiple family members suggest a genetic predisposition.

Environmental and Other Triggers

While genetics contribute to susceptibility, environmental factors may trigger the immune response leading to arterial inflammation.

  • Infections: Some researchers suspect bacterial or viral infections may contribute to immune system dysregulation, leading to an autoimmune attack on blood vessels. 
  • Immune system overactivation: Exposure to certain toxins or pollutants has been proposed as a possible factor, though the evidence remains limited.
  • Autoimmune diseases: Some cases of Takayasu’s arteritis have been reported in people with other (pre-existing) autoimmune conditions, such as lupus or rheumatoid arthritis. This suggests a link between immune system dysfunction and the disease.

Recognizing the Symptoms

The symptoms of Takayasu’s arteritis can vary widely depending on which arteries are affected and how advanced the disease is. Early signs are often nonspecific and can be mistaken for more common conditions, delaying diagnosis. As the disease progresses, reduced blood flow to vital organs can lead to more severe complications.

Common Symptoms

Takayasu's arteritis symptoms vary depending on which arteries are affected and how far the disease has progressed. Early signs are often vague and may be mistaken for more common illnesses. As the condition advances, blood flow restrictions can cause more severe symptoms, requiring immediate medical attention. 

Common early symptoms include:

  • Fatigue and weakness
  • Low-grade fever
  • Muscle and joint pain
  • Unintended weight loss 

Cardiovascular Symptoms

As inflammation causes narrowing and damage to large arteries, blood flow to organs and limbs becomes restricted, leading to more noticeable vascular symptoms.

  • Hypertension: If the arteries supplying the kidneys are affected, blood pressure can become dangerously elevated.
  • Weak or absent pulse in the arms or legs ("pulseless disease"): Blockages in major arteries can reduce or eliminate detectable pulses.
  • Chest pain or shortness of breath: Decreased blood supply to the heart can lead to angina or heart failure symptoms.
  • Dizziness or fainting: Poor circulation to the brain may cause lightheadedness, particularly when standing.
  • Claudication (pain in the arms or legs with use): Due to insufficient oxygen supply, worsening with physical activity.

Rare and Atypical Symptoms

In some cases, Takayasu’s arteritis can cause complications in other organs:

  • Vision problems (Takayasu retinopathy): Decreased blood flow to the eyes may result in blurred vision, double vision, or, in severe cases, irreversible blindness.
  • Numbness or weakness in the limbs: When arteries supplying the brain or spinal cord are affected, neurological symptoms like weakness, tingling, or even strokes may occur.
  • Kidney dysfunction: If the renal arteries are involved, reduced kidney function can lead to fluid retention, swelling, and further complications with blood pressure regulation.

Recognizing the warning signs early can lead to a quicker diagnosis and better disease management.

Diagnosis of Takayasu's Arteritis

Because early symptoms mimic other conditions, diagnosing Takayasu’s arteritis can be challenging. Doctors confirm the disease using a combination of clinical evaluations and imaging tests.

Clinical Evaluation

A healthcare provider will review the patient's symptoms, medical history, and physical examination findings, including checking for weak pulses or differences in blood pressure between arms.

Diagnostic Tests

To confirm the diagnosis and assess the severity of arterial involvement, a combination of tests may be used:

  • Blood tests: Inflammatory markers such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are often elevated, suggesting ongoing inflammation. However, these markers are nonspecific and can be high in other conditions as well.
  • Imaging: Advanced imaging can help visualize arterial abnormalities:
    • Magnetic Resonance Angiography (MRA): Provides detailed images of blood vessels and can detect narrowing, inflammation, or aneurysms.
    • Computed Tomography Angiography (CTA): Useful for visualizing arterial damage and stenosis in the aorta and major branches.
    • Doppler ultrasound: Helps assess blood flow and detect arterial narrowing in the carotid and subclavian arteries.
  • Angiography: A contrast dye is injected into blood vessels, allowing doctors to see blockages or narrowing in real-time. While previously a gold standard, angiography is now often replaced by non-invasive imaging techniques like MRA or CTA.

Differential Diagnosis

Since Takayasu’s arteritis shares symptoms with other vasculitides and autoimmune diseases, doctors must rule out similar conditions, including:

Treatment Options

Takayasu’s arteritis requires long-term management to control inflammation and prevent complications.

Medical Treatments

The primary goal of medical treatment is to control inflammation and slow disease progression. A combination of medications may be used, depending on the severity of symptoms and response to therapy.

  • Corticosteroids: Corticosteroids are the first-line treatment for Takayasu’s arteritis. They help suppress immune activity and reduce inflammation in the blood vessels. 
  • Immunosuppressants: If corticosteroids alone are not effective or cause significant side effects, additional immunosuppressive drugs such as methotrexate, azathioprine, or mycophenolate mofetil may be prescribed to help control the immune response.
  • Biologic therapies: Targeted biologic drugs, such as tumor necrosis factor (TNF) inhibitors (e.g., infliximab, adalimumab) or interleukin-6 (IL-6) inhibitors (e.g., tocilizumab), may be used in severe or refractory cases. These help reduce inflammation by blocking specific immune pathways.
  • Antiplatelet or anticoagulant therapy: In some cases, blood thinners like aspirin may be recommended to reduce the risk of blood clots, particularly if there is significant arterial narrowing.

Surgical Interventions

For patients with severe arterial narrowing, aneurysms, or organ damage due to reduced blood flow, surgery may be necessary to restore circulation and prevent serious complications.

  • Vascular bypass surgery: A surgeon creates an alternate route for blood flow by grafting a healthy blood vessel around the blocked or narrowed artery.
  • Angioplasty and stenting: A minimally invasive procedure where a small balloon is inserted into a narrowed artery and inflated to widen it. A stent (a tiny mesh tube) may be placed to keep the artery open and improve blood flow.
  • Aneurysm repair: If an artery develops an aneurysm (a weakened, bulging section), surgery may be required to reinforce or remove the damaged area to prevent rupture.

Integrative and Functional Approaches

Alongside medical treatments, lifestyle changes and complementary therapies can help improve overall health:

  • Diet and nutrition: An anti-inflammatory diet can help reduce inflammation.
  • Stress management: Techniques such as meditation or gentle yoga may improve quality of life.

Living with Takayasu's Arteritis

Managing Takayasu’s arteritis requires ongoing medical care, lifestyle adjustments, and emotional support.

Managing Daily Life

Patients can take proactive steps to improve their well-being:

  • Following prescribed treatments and attending regular check-ups
  • Monitoring blood pressure and heart health
  • Avoiding smoking and limiting alcohol intake

Long-Term Prognosis

While Takayasu’s arteritis is a chronic condition, early diagnosis, and proper management can help many patients maintain a good quality of life. Disease progression varies, with some individuals experiencing periods of remission.

[signup]

Key Takeaways

  • Takayasu’s arteritis is a rare inflammatory disease that affects large blood vessels, primarily the aorta.
  • Symptoms often start with fatigue and fever but progress to serious cardiovascular and neurological issues.
  • Diagnosis requires imaging and blood tests to confirm arterial inflammation and rule out other conditions.
  • Treatment involves corticosteroids and immunosuppressants, with surgery needed in severe cases.
  • Lifestyle modifications and support systems play a crucial role in long-term disease management.
  • Early diagnosis and consistent treatment improve outcomes, helping patients maintain their quality of life.

Takayasu’s arteritis is a complex but manageable condition. With early detection, appropriate treatment, and lifestyle adjustments, many patients can lead fulfilling lives. Ongoing research continues to improve treatment options, offering hope for better management in the future.

If you or a loved one has been diagnosed with Takayasu’s arteritis, consult a healthcare professional to create a personalized treatment plan.

The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Achuff, J. (2024, February 23). Extinguishing the Habit, Igniting Life: The Transformative Impact of Quitting Smoking. Rupa Health. https://www.rupahealth.com/post/extinguishing-the-habit-igniting-life-the-transformative-impact-of-quitting-smoking

American College of Rheumatology. (n.d.). Takayasu’s Arteritis. Rheumatology.org. https://rheumatology.org/patients/takayasus-arteritis

Blake, K. (2023, May 22). Anti Inflammatory Diet 101: What to Eat and Avoid Plus Specialty Labs To Monitor Results. Rupa Health. https://www.rupahealth.com/post/anti-inflammatory-diet

Bryant, A. (2024, September 24). Symptoms of rheumatoid arthritis: Recognizing the early signs. Rupa Health. https://www.rupahealth.com/post/symptoms-of-rheumatoid-arthritis-recognizing-the-early-signs

Bryant, A. (2025, February 12). Myocardial Infarction (Heart Attack): Causes, Symptoms and Treatment Guide. Rupa Health. https://www.rupahealth.com/post/myocardial-infarction-heart-attack-causes-symptoms-and-treatment-guide

Christie, J. (2024, May 17). How to Spot the Top Warning Signs of a Stroke. Rupa Health. https://www.rupahealth.com/post/how-to-spot-the-top-warning-signs-of-a-stroke

Cleveland Clinic. (n.d.). Takayasu’s Arteritis: Symptoms, Tests, Treatment & Outlook. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/7097-takayasus-arteritis

Cleveland Clinic. (2024, February 15). Atherosclerosis: Types, Causes, & Treatments. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/16753-atherosclerosis-arterial-disease

Cloyd, J. (2023, December 11). How to Interpret Your CRP Blood Test. Rupa Health. https://www.rupahealth.com/post/how-to-interpret-your-crp-blood-test

Cloyd, J. (2024, September 12). High Sed (Sedimentation) Rate Explained: Lab Tests, Biomarkers, and Lowering Strategies. Rupa Health. https://www.rupahealth.com/post/high-sed-sedimentation-rate-explained-lab-tests-biomarkers-and-lowering-strategies

Cox, A. D. (2022, August 10). Chronic Fatigue, Chest Pain, Stiffness, And Headaches Are All Signs Of This Autoimmune Disease. Rupa Health. https://www.rupahealth.com/post/natural-treatment-for-lupus

Espinoza, J., Ai, S., & Matsumura, I. (2018). New Insights on the Pathogenesis of Takayasu Arteritis: Revisiting the Microbial Theory. Pathogens, 7(3), 73. https://doi.org/10.3390/pathogens7030073

John Hopkins Medicine. (2024). Magnetic Resonance Angiography (MRA). Www.hopkinsmedicine.org. https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/magnetic-resonance-angiography-mra

Malani, S. (2023, February 22). Inflammatory Markers 101: How To Interpret. Rupa Health. https://www.rupahealth.com/post/inflammatory-markers-101-what-do-they-mean

Mason, J. C. (2018). Surgical intervention and its role in Takayasu arteritis. Best Practice & Research Clinical Rheumatology, 32(1), 112–124. https://doi.org/10.1016/j.berh.2018.07.008

Mayo Clinic. (2018). Claudication - Symptoms and Causes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/claudication/symptoms-causes/syc-20370952

Morishita, K. A., Rosendahl, K., & Brogan, P. A. (2011). Familial Takayasu arteritis - a pediatric case and a review of the literature. 9(1). https://doi.org/10.1186/1546-0096-9-6

Neibling, K. (2023, April 26). Complementary and Integrative Medicine Treatments for Hypertension and Cardiovascular Disease. Rupa Health. https://www.rupahealth.com/post/complementary-and-integrative-medicine-treatments-for-hypertension-and-cardiovascular-disease

NHS . (2023, January 30). Angiography. NHS. https://www.nhs.uk/conditions/Angiography/

Ohigashi, H., Tamura, N., Ebana, Y., Harigai, M., Maejima, Y., Ashikaga, T., & Isobe, M. (2016). Effects of immunosuppressive and biological agents on refractory Takayasu arteritis patients unresponsive to glucocorticoid treatment. Journal of Cardiology, 69(5), 774–778. https://doi.org/10.1016/j.jjcc.2016.07.009

Peter, J., David, S., Danda, D., Peter, J. V., Horo, S., & Joseph, G. (2011). OCULAR MANIFESTATIONS OF TAKAYASU ARTERITIS. Retina, 31(6), 1170–1178. https://doi.org/10.1097/iae.0b013e3181fe540b

Radiology (ACR), R. S. of N. A. (RSNA) and A. C. of. (2020, June 15). Angioplasty and Vascular Stenting. Radiologyinfo.org. https://www.radiologyinfo.org/en/info/angioplasty

Radiology (ACR), R. S. of N. A. (RSNA) and A. C. of. (2023). CT Angiography (CTA). Radiologyinfo.org. https://www.radiologyinfo.org/en/info/angioct

Renauer, P., & Sawalha, A. H. (2017). The genetics of Takayasu arteritis. La Presse Médicale, 46(7-8), e179–e187. https://doi.org/10.1016/j.lpm.2016.11.031

Teeter, L. A. (2023, April 3). Mental health benefits of yoga and meditation. Rupa Health. https://www.rupahealth.com/post/mental-health-benefits-of-yoga-and-meditation

Thapa Magar, M., Kafle, S., Poudel, A., Patel, P., & Cancarevic, I. (2021). Takayasu’s Arteritis and Its Association With Mycobacterium Tuberculosis: A Systematic Review. Cureus. https://doi.org/10.7759/cureus.16927

Thomsen, H., Li, X., Sundquist, K., Sundquist, J., Försti, A., & Hemminki, K. (2020). Familial risks between giant cell arteritis and Takayasu arteritis and other autoimmune diseases in the population of Sweden. Scientific Reports, 10(1). https://doi.org/10.1038/s41598-020-77857-7

Trinidad, B., Surmachevska, N., & Lala, V. (2021). Takayasu Arteritis. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK459127/

Ueno, M. (2010). Antiplatelet therapy in the treatment of Takayasu arteritis. Circulation Journal : Official Journal of the Japanese Circulation Society, 74(6), 1079–1080. https://doi.org/10.1253/circj.cj-10-0358

University of Chicago Medicine. (n.d.). Types of Aneurysm. Www.uchicagomedicine.org. https://www.uchicagomedicine.org/conditions-services/heart-vascular/aortic-disease/types-of-aneurysm-repair

Vasculitis Foundation. (2024). Takayasu Arteritis – Vasculitis Foundation. Vasculitisfoundation.org. https://vasculitisfoundation.org/education/vasculitis-types/takayasu-arteritis/

Waldfogel, M. P. (2024, January 19). Beyond Dry January - How to Help Patients Reduce or Eliminate Alcohol Consumption. Rupa Health. https://www.rupahealth.com/post/beyond-dry-january---how-to-help-patients-reduce-or-eliminate-alcohol-consumption

Yang, H. (2023, February). Giant Cell Arteritis. Rheumatology.org. https://rheumatology.org/patients/giant-cell-arteritis

Young, J., & Patel, S. K. (2021). Peripheral Vascular Bypass. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK499827/

Zanoli, L., Briet, M., Empana, J. P., Cunha, P. G., Mäki-Petäjä, K. M., Protogerou, A. D., Tedgui, A., Touyz, R. M., Schiffrin, E., Spronck, B., Bouchard, P., Vlachopoulos, C., Bruno, R. M., & Boutouyrfe, P. (2020). Vascular consequences of inflammation: a position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society. Journal of Hypertension, 38(9), 1682–1698. https://doi.org/10.1097/HJH.0000000000002508

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Cardiology
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.